Point72 Middle East Fze Atri Cure, Inc. Transaction History

Point72 Middle East Fze

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $715,025 - $937,400	21,674 Added 491.25%	26,086 $931,000
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $296,022 - $415,598	-7,199 Reduced 62.0%	4,412 $193,000
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $469,548 - $575,905	11,611 New	11,611 $573,000
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $62,574 - $88,684	1,869 New	1,869 $0

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.